screenat45 Story
Aspirin use following adjuvant therapy does not improve disease outcomes in colorectal cancer patients
A large phase 3 trial (ASCOLT) found that daily aspirin use for 3 years after standard adjuvant therapy (treatment given...
Early-Life Exposure to Bacterial Toxin Linked to Increased Risk of Early-Onset Colorectal Cancer
A recent study published in Nature by Díaz-Gay et al. has linked early-life exposure to a bacterial toxin called colibactin,...
Improving Safety in Polyp Removal: The Closure Trial
Colorectal cancer often starts as a small polyp that slowly grows until it becomes cancerous. Research indicates that once a...
The ABLATION Trial: Evaluating New Techniques for Safer, More Effective Removal
Colorectal cancer often begins as a small polyp in the colon that slowly grows until it becomes cancerous. Research shows...
United for Action: Avitia and Colorectal Cancer Canada Advance Patient Outcomes
Mar 2025 United for Action: Avitia and Colorectal Cancer Canada Advance Patient Outcomes While colorectal cancer remains one of the...
Aspirin Lowers Colorectal Cancer Recurrence Risk in Patients with P13K Mutations
March 2025 A phase 3 trial presented at the 2025 Gastrointestinal Cancers Symposium showed that three years of aspirin use...
